These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5935448)

  • 1. A liver glycogen assay of anti-inflammatory steroids on chicks and embryos.
    Newman J; Gyermek L
    Proc Soc Exp Biol Med; 1966 Feb; 121(2):386-90. PubMed ID: 5935448
    [No Abstract]   [Full Text] [Related]  

  • 2. Measurement of dermal atrophy induced by topical steroids using a radiographic technique.
    James MP; Black MM; Sparkes CG
    Br J Dermatol; 1977 Mar; 96(3):303-5. PubMed ID: 322693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desonide, a potent nonfluorinated topical steroid, vasoconstriction assay and clinical trial.
    Smith EB; Gregory JF; Bartruff JK
    South Med J; 1973 Mar; 66(3):325-9. PubMed ID: 4570656
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of corticosteroids on fibroblast functions.
    Berliner DL; Nabors CJ
    J Reticuloendothel Soc; 1967 Jul; 4(4):284-313. PubMed ID: 6056840
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of clobetasone butyrate and other topical steroids on skin thickness of the domestic pig.
    Winter GD; Wilson L
    Br J Dermatol; 1976 May; 94(5):545-50. PubMed ID: 1268065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The physical, animal and human pharmacologic, and toxicologic properties of desonide, a new, topically active, antiinflammatory steroid.
    Phillips BM; Sanen FJ; Leeling JL; Hammes TL; Hartnagel RE; Sancilio LF; Lorenzetti OJ; Kraus PJ
    Toxicol Appl Pharmacol; 1971 Dec; 20(4):522-37. PubMed ID: 5143593
    [No Abstract]   [Full Text] [Related]  

  • 7. Vasoconstrictor and systemic activities of topical steroids.
    Child KJ; English AF; Gilbert HG; Hewitt A; Woollett EA
    Arch Dermatol; 1968 Apr; 97(4):407-10. PubMed ID: 4966856
    [No Abstract]   [Full Text] [Related]  

  • 8. The influence of corticosteroids, griseofulvin and tolnaftate on the in vitro growth of two dermatophytes.
    Caplan RM; Clabaugh W
    J Invest Dermatol; 1969 Mar; 52(3):247-54. PubMed ID: 5774352
    [No Abstract]   [Full Text] [Related]  

  • 9. COMPARISON OF ANTI-GRANULOMA, THYMOLYTIC AND GLUCOCORTICOID ACTIVITIES OF ANTI-INFLAMMATORY STEROIDS.
    LERNER LJ; TURKHEIMER AR; BIANCHI A; SINGER FM; BORMAN A
    Proc Soc Exp Biol Med; 1964 Jun; 116():385-8. PubMed ID: 14189145
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimentally induced steroid atrophy in the domestic pig and man.
    Winter GD; Burton JL
    Br J Dermatol; 1976 Mar; 94 suppl 12():107-9. PubMed ID: 1268070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of glycyrrhizin on the action cortisone].
    Nanahoshi M
    Nihon Naibunpi Gakkai Zasshi; 1967 Mar; 42(12):1312-9. PubMed ID: 6067711
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of wound healing by topical steroids.
    Marks JG; Cano C; Leitzel K; Lipton A
    J Dermatol Surg Oncol; 1983 Oct; 9(10):819-21. PubMed ID: 6619384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative bio-availability of proprietary topical corticosteroid preparations; vasoconstrictor assays on thirty creams and gels.
    Barry BW; Woodford R
    Br J Dermatol; 1974 Sep; 91(3):323-38. PubMed ID: 4611447
    [No Abstract]   [Full Text] [Related]  

  • 14. The inhibition of croton oil-promoted mouse skin tumorigenesis by steroid hormones.
    Belman S; Troll W
    Cancer Res; 1972 Mar; 32(3):450-4. PubMed ID: 5061300
    [No Abstract]   [Full Text] [Related]  

  • 15. [PHARMACOLOGY OF SYNTHETIC CORTICAL STEROIDS OF ANTIINFLAMMATORY ACTION].
    GIJON JR; RODRIGUEZMURCIA C; ALIADIAZ M
    An Real Acad Farm; 1963; 29():361-90. PubMed ID: 14122037
    [No Abstract]   [Full Text] [Related]  

  • 16. The characteristic feature of glucocorticoids after local application with reference to leucocyte migration and protein exudation.
    Ishikawa H; Mori Y; Tsurufuji S
    Eur J Pharmacol; 1969 Aug; 7(2):201-5. PubMed ID: 5345995
    [No Abstract]   [Full Text] [Related]  

  • 17. Vasoconstrictor potency of corticoids: intradermal injection.
    Sutton PM; Feldmann RJ; Maibach HI
    J Invest Dermatol; 1971 Dec; 57(6):371-6. PubMed ID: 5127971
    [No Abstract]   [Full Text] [Related]  

  • 18. Bioassay system for formulations of topically applied glucocorticosteroids.
    Stoughton RB
    Arch Dermatol; 1972 Dec; 106(6):825-7. PubMed ID: 4639246
    [No Abstract]   [Full Text] [Related]  

  • 19. [Practical importance and the criteria of value of external corticoids].
    Weirich EG
    Wien Med Wochenschr; 1966 Aug; 116(32):665-73. PubMed ID: 5995274
    [No Abstract]   [Full Text] [Related]  

  • 20. Bio-assay of corticosteroids for topical application.
    Spearman RI; Jarrett A
    Br J Dermatol; 1975 May; 92(5):581-4. PubMed ID: 1174471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.